Bacterial adherence and biofilm formation on medical implants: A review

Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine

Volumn 228, Issue 10, 2014, Pages 1083-1099

  Veerachamy, Suganthan ^a   Yarlagadda, Tejasri ^b   Manivasagam, Geetha ^a   Yarlagadda, Prasad Kdv ^c  

^a VIT UNIVERSITY   (India)

^b Newcastle University Medicine Malaysia   (United Kingdom)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

bacteria; Biofilm; infections; medical implants; nano polymer coatings

Indexed keywords

ADHESION; BACTERIA; BIOFILMS; BIOMEDICAL EQUIPMENT; METAL IMPLANTS; POLYMERIC IMPLANTS; SURFACE TREATMENT; TISSUE;

ANTI-BACTERIAL ACTIVITY; BACTERIAL ADHERENCE; BIOLOGICAL BEHAVIOR; CHEMICAL COMPOSITIONS; CHEMICAL TECHNIQUES; INFECTIONS; MEDICAL IMPLANTS; NANO POLYMERS;

FUNCTIONAL POLYMERS;

ANTIINFECTIVE AGENT; BIOMATERIAL;

BACTERIUM ADHERENCE; BIOFILM; CHEMISTRY; DISINFECTION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; INSTRUMENT STERILIZATION; MEDICAL DEVICE CONTAMINATION; MICROBIOLOGY; PHYSIOLOGY; PREVENTION AND CONTROL; PROCEDURES; PROSTHESES AND ORTHOSES;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOFILMS; COATED MATERIALS, BIOCOMPATIBLE; DISINFECTION; EQUIPMENT CONTAMINATION; PROSTHESES AND IMPLANTS; STERILIZATION;

EID: 84924291070     PISSN: 09544119     EISSN: 20413033     Source Type: Journal    
DOI: 10.1177/0954411914556137     Document Type: Review

References (202)

1. Bakke R, Trulear M, Robinson J, et al. Activity of Pseudomonas aeruginosa in biofilms: steady state. Biotechnol Bioeng. 1984 ; 26 (12). 1418-1424
2. Upadhyayula VK, Gadhamshetty V. Appreciating the role of carbon nanotube composites in preventing biofouling and promoting biofilms on material surfaces in environmental engineering: a review. Biotechnol Adv. 2010 ; 28 (6). 802-816
3. Cheng G, Zhang Z, Chen S, et al. Inhibition of bacterial adhesion and biofilm formation on zwitterionic surfaces. Biomaterials. 2007 ; 28 (29). 4192-4199
4. Pang CM, Hong P, Guo H, et al. Biofilm formation characteristics of bacterial isolates retrieved from a reverse osmosis membrane. Environ Sci Technol. 2005 ; 39 (19). 7541-7550
5. Goldberg J. Biofilms and antibiotic resistance: a genetic linkage. Trends Microbiol. 2002 ; 10 (6). 264
6. Peng J-S, Tsai W-C, Chou C-C. Inactivation and removal of Bacillus cereus by sanitizer and detergent. Int J Food Microbiol. 2002 ; 77 (1). 11-18
7. Chen M, Zhang Z, Bott T. Direct measurement of the adhesive strength of biofilms in pipes by micromanipulation. Biotechnol Tech. 1998 ; 12 (12). 875-880
8. Bernier SP, Silo-Suh L, Woods DE, et al. Comparative analysis of plant and animal models for characterization of Burkholderia cepacia virulence. Infect Immun. 2003 ; 71 (9). 5306-5313
9. Costerton J, Stewart PS, Greenberg E. Bacterial biofilms: a common cause of persistent infections. Science. 1999 ; 284 (5418). 1318-1322
10. Kunin CM. Blockage of urinary catheters: role of microorganisms and constituents of the urine on formation of encrustations. J Clin Epidemiol. 1989 ; 42 (9). 835-842
11. Reid G. Biofilms in infectious disease and on medical devices. Int J Antimicrob Agents. 1999 ; 11 (3). 223-226
12. Dickinson GM, Bisno AL. Infections associated with indwelling devices: infections related to extravascular devices. Antimicrob Agents Chemother. 1989 ; 33 (5). 602-607
13. Habash M, Reid G. Microbial biofilms: their development and significance for medical device-related infections. J Clin Pharmacol. 1999 ; 39 (9). 887-898
14. Muller E, Hübner J, Gutierrez N, et al. Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun. 1993 ; 61 (2). 551-558
15. Heilmann C, Hussain M, Peters G, et al. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol. 1997 ; 24 (5). 1013-1024
16. Tormo MÁ, Knecht E, Götz F, et al. Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer?. Microbiology. 2005 ; 151 (7). 2465-2475
17. Mack D, Fischer W, Krokotsch A, et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol. 1996 ; 178 (1). 175-183
18. Allison DG. The biofilm matrix. Biofouling. 2003 ; 19 (2). 139-150
19. Sutherland IW. The biofilm matrix - an immobilized but dynamic microbial environment. Trends Microbiol. 2001 ; 9 (5). 222-227
20. Daniels R, Vanderleyden J, Michiels J. Quorum sensing and swarming migration in bacteria. FEMS Microbiol Rev. 2004 ; 28 (3). 261-289
21. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis. 2002 ; 8 (9). 881-890
22. Eberhard A, Burlingame A, Eberhard C, et al. Structural identification of autoinducer of Photobacterium fischeri luciferase. Biochemistry. 1981 ; 20 (9). 2444-2449
23. Parsek MR, Greenberg E. Sociomicrobiology: the connections between quorum sensing and biofilms. Trends Microbiol. 2005 ; 13 (1). 27-33
24. Xiong Y, Liu Y. Biological control of microbial attachment: a promising alternative for mitigating membrane biofouling. Appl Microbiol Biotechnol. 2010 ; 86 (3). 825-837
25. Novick RP Cell-cell signaling in bacteria. Dunny GM Winans SC, ed. Washington, DC: ASM Press ; 1999: 129-146.
26. Wesson CA, Liou LE, Todd KM, et al. Staphylococcus aureus Agr and Sar global regulators influence internalization and induction of apoptosis. Infect Immun. 1998 ; 66 (11). 5238-5243
27. Fuqua C, Winans SC, Greenberg EP. Census and consensus in bacterial ecosystems: the LuxR-LuxI family of quorum-sensing transcriptional regulators. Annu Rev Microbiol. 1996 ; 50 (1). 727-751
28. Davies DG, Parsek MR, Pearson JP, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998 ; 280 (5361). 295-298
29. Dunne WM. Bacterial adhesion: seen any good biofilms lately?. Clin Microbiol Rev. 2002 ; 15 (2). 155-166
30. Brugnoni L, Lozano J, Cubitto M. Potential of yeast isolated from apple juice to adhere to stainless steel surfaces in the apple juice processing industry. Food Res Int. 2007 ; 40 (3). 332-340
31. Gilbert P, Evans D, Brown M. Formation and dispersal of bacterial biofilms in vivo and in situ. J Appl Bacteriol. 1993 ; 74 (S22). 67S - 78S
32. Korber DR, Lawrence JR, Lappin-Scott HM, et al. Growth of microorganisms on surfaces. Microbial Biofilms. 1995 ;: 15-45
33. Prakash B, Veeregowda B, Krishnappa G. Biofilms: a survival strategy of bacteria. Curr Sci. 2003 ; 85 (9). 1299-1307
34. Bryers JD. Medical biofilms. Biotechnol Bioeng. 2008 ; 100 (1). 1-18
35. Darouiche RO, Farmer J, Chaput C, et al. Anti-infective efficacy of antiseptic-coated intramedullary nails. J Bone Joint Surg Am. 1998 ; 80 (9). 1336-1340
36. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004 ; 2 (2). 95-108
37. Davey ME, O'toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev. 2000 ; 64 (4). 847-867
38. Blaker J, Nazhat S, Boccaccini A. Development and characterisation of silver-doped bioactive glass-coated sutures for tissue engineering and wound healing applications. Biomaterials. 2004 ; 25 (7). 1319-1329
39. Rodrigues L, Banat IM, Teixeira J, et al. Strategies for the prevention of microbial biofilm formation on silicone rubber voice prostheses. J Biomed Mater Res B Appl Biomater. 2007 ; 81 (2). 358-370
40. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis. 2001 ; 33: 1567-1572
41. Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev. 2006 ; 35 (9). 780-789
42. Lynch AS, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med. 2008 ; 59: 415-428
43. Zilberman M, Elsner JJ. Antibiotic-eluting medical devices for various applications. J Control Release. 2008 ; 130 (3). 202-215
44. Gristina AG, Naylor PT, Myrvik QN. Pathogenesis of wound and biomaterial-associated infections. Wadström T Eliasson I Holder I, ed. London: Springer ; 1990: 193-216.
45. Castelli P, Caronno R, Ferrarese S, et al. New trends in prosthesis infection in cardiovascular surgery. Surg Infect. 2006 ; 7: S45 - S47
46. Izano EA, Amarante MA, Kher WB, et al. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol. 2008 ; 74 (2). 470-476
47. Rohde H, Burandt EC, Siemssen N, et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials. 2007 ; 28 (9). 1711-1720
48. Pizarro-Cerda J, Cossart P. Bacterial adhesion and entry into host cells. Cell. 2006 ; 124 (4). 715-727
49. Arciola CR, Visai L, Testoni F, et al. Concise survey of Staphylococcus aureus virulence factors that promote adhesion and damage to peri-implant tissues. Int J Artif Organs. 2011 ; 34 (9). 771-780
50. Campoccia D, Montanaro L, Arciola CR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials. 2006 ; 27 (11). 2331-2339
51. Montanaro L, Campoccia D, Arciola CR. Advancements in molecular epidemiology of implant infections and future perspectives. Biomaterials. 2007 ; 28 (34). 5155-5168
52. Montanaro L, Testoni F, Poggi A, et al. Emerging pathogenetic mechanisms of the implant-related osteomyelitis by. Staphylococcus aureus. Int J Artif Organs. 2011 ; 34 (9). 781-788
53. Chang CC, Merritt K. Infection at the site of implanted materials with and without preadhered bacteria. J Orthop Res. 1994 ; 12: 526-531
54. Fux CA, Stoodley P, Hall-Stoodley L, et al. Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther. 2003 ; 1 (4). 667-683
55. Cirioni O, Giacometti A, Ghiselli R, et al. RNA III-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. J Infect Dis. 2006 ; 193: 180-186
56. Balaban N, Giacometti A, Cirioni O, et al. Use of the quorum-sensing inhibitor RNA III inhibiting peptide to prevent biofilm formation in vivo by drug resistant. Staphylococcus epidermidis. J Infect Dis. 2003 ; 187 (4). 625-630
57. Baveja JK, Willcox MD, Hume EB, et al. Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials. 2004 ; 25: 5003-5012
58. Kuama A. Rózalski M, Walencka E, et al. Antimicrobial activity of diterpenoids from hairy roots of Salvia sclarea L.: salvipisone as a potential anti-biofilm agent active against antibiotic resistant staphylococci. Phytomedicine. 2007 14: 31-35
59. Valencia-Burton M, Oki M, Johnson J, et al. Different mating-type-regulated genes affect the DNA repair defects of Saccharomyces RAD51, RAD52 and RAD55 mutants. Genetics. 2006 ; 174 (1). 41-55
60. Pérez-Giraldo C, Cruz-Villalón G, Sánchez-Silos R, et al. In vitro activity of allicin against Staphylococcus epidermidis and influence of subinhibitory concentrations on biofilm formation. J Appl Microbiol. 2003 ; 95 (4). 709-711
61. Aslam S, Trautner BW, Ramanathan V, et al. Combination of tigecycline and N-acetyl cysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob Agents Chemother. 2007 ; 51: 1556-1558
62. Curtin JJ, Donlan RM. Using bacteriophages to reduce formation of catheter-associated biofilms by. Staphylococcus epidermidis. Antimicrob Agents Chemother. 2006 ; 50: 1268-1275
63. Cerca N, Oliveira R, Azeredo J. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K. Lett Appl Microbiol. 2007 ; 45: 313-317
64. Bryers JD, Ratner BD. Bioinspired implant materials befuddle bacteria. ASM News. 2004 ; 70: 232-237
65. McKenney D, Pouliot K, Wang Y, et al. Vaccine potential of poly-1-6-beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol. 2000 ; 83: 37-44
66. Pei L, Palma M, Nilsson M, et al. Functional studies of a fibrinogen binding protein from. Staphylococcus epidermidis. Infect Immun. 1999 ; 67: 4525-4530
67. Pei L, Flock JI. Functional study of antibodies against a fibrogenin-binding protein in Staphylococcus epidermidis adherence to polyethylene catheters. J Infect Dis. 2001 ; 184: 52-55
68. Rennermalm A, Nilsson M, Flock J-I. Fibrinogen binding protein (Fbe) of S. epidermidis is a target for opsonic antibodies. Infect Immun. 2004 ; 72: 3081-3083
69. Rohde H, Burdelski C, Bartscht K, et al. Induction of Staphylococcus epidermidis biofilm formation via proteolytical processing of the accumulation associated protein by staphylococcal and host proteases. Mol Microbiol. 2005 ; 55: 1883-1895
70. Johansen C, Falholt P, Gram L. Enzymatic removal and disinfection of bacterial biofilms. Appl Environ Microbiol. 1997 ; 63: 3724-3728
71. Wu JA, Kusuma C, Mond JJ, et al. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother. 2003 ; 47: 3407-3414
72. Donelli G, Francolini I, Kaplan JB. Synergistic activity of dispersin B and cefamandole nafate in inhibition of Staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother. 2007 ; 51 (8). 2733-2740
73. Selan L, Berlutti F, Passariello C, et al. Proteolytic enzymes: a new treatment strategy for prosthetic infections?. Antimicrob Agents Chemother. 1993 ; 37: 2618-2621
74. Mecikoglu M, Saygi B, Yildirim Y, et al. The effect of proteolytic enzyme serratiopeptidase in the treatment of experimental implant-related infection. J Bone Joint Surg Am. 2006 ; 88: 1208-1214
75. Boelens JJ, van der Poll T, Dankert1 J, et al. Interferon protects against biomaterial-associated Staphylococcus epidermidis infection in mice. J Infect Dis. 2000 ; 181 (3). 1167-1171
76. Lopez-Lopez G, Pascual A, Perea E. Effect of plastic catheter material on bacterial adherence and viability. J Med Microbiol. 1991 ; 34 (6). 349-353
77. Shenkman B, Varon D, Tamarin I, et al. Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions. J Med Microbiol. 2002 ; 51 (9). 747-754
78. Carratalà J, Niubó J, Fernández-Sevilla A, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother. 1999 ; 43 (9). 2200-2204
79. Raad I, Hachem R, Tcholakian RK, et al. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother. 2002 ; 46 (2). 327-332
80. Veenstra DL, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. JAMA. 1999 ; 281 (3). 261-267
81. Manierski C, Besarab A. Antimicrobial locks: putting the lock on catheter infections. Adv Chronic Kidney Dis. 2006 ; 13 (3). 245-258
82. Matl FD, Obermeier A, Repmann S, et al. New anti-infective coatings of medical implants. Antimicrob Agents Chemother. 2008 ; 60: 1551-1571
83. Subbiahdoss G, Grijpma DW, Van der Mei HC, et al. Microbial biofilm growth versus tissue integration on biomaterials with different wettabilities and a polymer-brush coating. J Biomed Mater Res A. 2010 ; 94 (2). 533-538
84. Wu P, Grainger DW. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials. 2006 ; 27 (11). 2450-2467
85. Stigter M, Bezemer J, De Groot K, et al. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release. 2004 ; 99 (1). 127-137
86. Price JS, Tencer AF, Arm DM, et al. Controlled release of antibiotics from coated orthopedic implants. J. Biomed Mater Res. 1996 ; 30 (3). 281-286
87. Avés EP, Estévez GF, Sader MS, et al. Hydroxyapatite coating by sol-gel on Ti-6Al-4V alloy as drug carrier. J Mater Sci Mater Med. 2009 ; 20 (2). 543-547
88. McCann Maureen T., Gilmore Brendan F, Gorman Sean P.. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. J Pharmacy and Pharmacology. 2008 ; 60: 1551-1571
89. Moroni A, Heikkila J, Magyar G, et al. Fixation strength and pin tract infection of hydroxyapatite-coated tapered pins. Clin Orthop Relat Res. 2001 ; 388: 209-217
90. Sandén B, Olerud C, Petren-Mallmin M, et al. Hydroxyapatite coating improves fixation of pedicle screws. A clinical study. J Bone Joint Surg Br. 2002 ; 84 (3). 387-391
91. Reading A, Rooney P, Taylor G. Quantitative assessment of the effect of 0.05% chlorhexidine on rat articular cartilage metabolism in vitro and in vivo. J Orthop Res. 2000 ; 18 (5). 762-767
92. Russell A, Day M. Antibacterial activity of chlorhexidine. J Hosp Infect. 1993 ; 25 (4). 229-238
93. DeJong MES, DeBerardino MTM, Brooks DE, et al. Antimicrobial efficacy of external fixator pins coated with a lipid stabilized hydroxyapatite/chlorhexidine complex to prevent pin tract infection in a goat model. J Trauma. 2001 ; 50 (6). 1008-1014
94. Gosheger G HJ, Ahrens H, Streitburger A, et al. Silver coated mega endoprostheses in a rabbit model - an analysis of the infection rate and toxicological side effects. Biomaterials. 2004 ; 25: 5547-5556
95. Lee D, Cohen RE, Rubner MF. Antibacterial properties of Ag nanoparticle loaded multilayers and formation of magnetically directed antibacterial microparticles. Langmuir. 2005 ; 21 (21). 9651-9659
96. Rameshbabu N, Sampathkumar TS, Prabhakar TG, et al. Antibacterial nanosized silver substituted hydroxyapatite: Synthesis and characterization. Wiley Interscience. 2006 ; 10: 1002
97. Knetsch ML, Koole LH. New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles. Polymer. 2011 ; 3 (1). 340-366
98. Song WH, Ryu HS, Hong SH. Antibacterial properties of Ag (or Pt)-containing calcium phosphate coatings formed by micro-arc oxidation. J Biomed Mater Res A. 2009 ; 88 (1). 246-254
99. Feng Q, Wu J, Chen G, et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and. Staphylococcus aureus. J Biomed Mater Res. 2000 ; 52 (4). 662-668
100. Webster TJ, Ergun C, Doremus RH, et al. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials. 2000 ; 21 (17). 1803-1810
101. Fujishima A. Electrochemical photolysis of water at a semiconductor electrode. Nature. 1972 ; 238: 37-38
102. Mills A, Le Hunte S. An overview of semiconductor photocatalysis. J Photochem Photobiol A Chem. 1997 ; 108 (1). 1-35
103. Sunada K, Watanabe T, Hashimoto K. Studies on photokilling of bacteria on TiO2 thin film. J Photochem Photobiol A Chem. 2003 ; 156 (1). 227-233
104. Boccaccini A, Karapappas P, Marijuan J, et al. TiO2 coatings on silicon carbide and carbon fibre substrates by electrophoretic deposition. J Mater Sci. 2004 ; 39 (3). 851-859
105. Sawase T, Jimbo R, Baba K, et al. Photo-induced hydrophilicity enhances initial cell behavior and early bone apposition. Clin Oral Implants Res. 2008 ; 19 (5). 491-496
106. Cheng C-L, Sun D-S, Chu W-C, et al. The effects of the bacterial interaction with visible-light responsive titania photocatalyst on the bactericidal performance. J Biomed Sci. 2009 ; 16 (1). 7
107. Huang Z, Maness P-C, Blake DM, et al. Bactericidal mode of titanium dioxide photocatalysis. J Photochem Photobiol A Chem. 2000 ; 130 (2). 163-170
108. Aita H, Hori N, Takeuchi M, et al. The effect of ultraviolet functionalization of titanium on integration with bone. Biomaterials. 2009 ; 30 (6). 1015-1025
109. Choi JY, Kim KH, Choy KC, et al. Photocatalytic antibacterial effect of TiO2 film formed on Ti and TiAg exposed to. Lactobacillus acidophilus. J Biomed Mater Res B Appl Biomater. 2007 ; 80 (2). 353-359
110. Liu H, Webster TJ. Nanomedicine for implants: a review of studies and necessary experimental tools. Biomaterials. 2007 ; 28 (2). 354-369
111. Ainslie KM, Tao SL, Popat KC, et al. In vitro immunogenicity of silicon-based micro- and nanostructured surfaces. ACS Nano. 2008 ; 2 (5). 1076-1084
112. Popat KC, Eltgroth M, LaTempa TJ, et al. Titania nanotubes: a novel platform for drug-eluting coatings for medical implants?. Small. 2007 ; 3 (11). 1878-1881
113. Popat KC, Leoni L, Grimes CA, et al. Influence of engineered titania nanotubular surfaces on bone cells. Biomaterials. 2007 ; 28 (21). 3188-3197
114. Pang X, Zhitomirsky I. Electrodeposition of hydroxyapatite-silver-chitosan nanocomposite coatings. Surf Coat Technol. 2008 ; 202 (16). 3815-3821
115. Huang H, Pierstorff E, Osawa E, et al. Active nanodiamond hydrogels for chemotherapeutic delivery. Nano Lett. 2007 ; 7 (11). 3305-3314
116. Joly V, Pangon B, Vallois J, et al. Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis. Antimicrob Agents Chemother. 1987 ; 31 (10). 1632-1639
117. Hancock E Artificial valve disease. The heart arteries and veins. New York: McGraw-Hill, Inc ; 1994: 1539-1545.
118. Heldman AW, Hartert TV, Ray SC, et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med. 1996 ; 101 (1). 68-76
119. Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery. Drugs. 2006 ; 66 (8). 1089-1106
120. Goeau-Brissonniere OA, Coggia M Infections associated with indwelling medical devices. Waldvogel FA Bisno AL, ed. Washington, DC: ASM Press ; 2000: 127-144.
121. Waldvogel FA, Bisno AL Infections associated with indwelling medical devices. Washington, DC: ASM Press ; 2000 :
122. Dever LL, Johnson W Infections associated with endotracheal intubation and tracheostomy. Washington, DC: ASM Press ; 2000: 307-324.
123. Oliver MJ, Schwab S Infections associated with indwelling medical devices. Waldvogel FA Bisno AL, ed. Washington, DC: ASM Press ; 2000: 345-372.
124. Hessen MT, Zuckerman JM, Kaye D Infections associated with foreign bodies in the urinary tract. Washington, DC: ASM Press ; 2000 :
125. Zhang L, Jiang Y, Ding Y, et al. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). J Nanopart Res. 2007 ; 9 (3). 479-489
126. Arbab AS, Wilson LB, Ashari P, et al. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed. 2005 ; 18 (6). 383-389
127. Taylor E, Webster TJ. Reducing infections through nanotechnology and nanoparticles. Int J Nanomedicine. 2011 ; 6: 1463-1473
128. Frey NA, Peng S, Cheng K, et al. Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage. Chem Soc Rev. 2009 ; 38 (9). 2532-2542
129. Gao J, Gu H, Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res. 2009 ; 42 (8). 1097-1107
130. Tran N, Webster TJ. Magnetic nanoparticles: biomedical applications and challenges. J Mater Chem. 2010 ; 20 (40). 8760-8767
131. Sinha N, Yeow J-W. Carbon nanotubes for biomedical applications. IEEE Trans Nanobioscience. 2005 ; 4 (2). 180-195
132. Webster TJ, Waid MC, McKenzie JL, et al. Nano-biotechnology: carbon nanofibres as improved neural and orthopaedic implants. Nanotechnology. 2004 ; 15 (1). 48
133. Doyle RJ Methods in enzymology volume 310: biofilms. San Diego, CA: Academic Press ; 1999 :
134. Hamilton M The biofilm laboratory: step-by-step protocols for experimental design, analysis, and data interpretation. Bozeman, MT: Cytergy ; 2003 :
135. Wolfaardt G, Korber D, Lawrence J, et al Manual of environmental microbiology. 3 rd ed. Washington, DC: ASM Press, 2007, pp.101-111. Hurst CJ Crawford RL Garland JL, ed. Washington, DC: ASM Press ; 2007: 101-111.
136. Heilmann C, Gerke C, Perdreau-Remington F, et al. Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect Immun. 1996 ; 64 (1). 277-282
137. Ali L, Khambaty F, Diachenko G. Investigating the suitability of the Calgary Biofilm Device for assessing the antimicrobial efficacy of new agents. Bioresour Technol. 2006 ; 97 (15). 1887-1893
138. Amorena B, Gracia E, Monzón M, et al. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother. 1999 ; 44 (1). 43-55
139. Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001 ; 183 (18). 5385-5394
140. De Prijck K, Nelis H, Coenye T. Efficacy of silver-releasing rubber for the prevention of Pseudomonas aeruginosa biofilm formation in water. Biofouling. 2007 ; 23 (6). 405-411
141. Krom BP, Cohen JB, McElhaney Feser GE, et al. Optimized candidal biofilm microtiter assay. J Microbiol Methods. 2007 ; 68 (2). 421-423
142. Stepanovi S, Djuki V, Djordjevi V, et al. Influence of the incubation atmosphere on the production of biofilm by staphylococci. Clin Microbiol Infect. 2003 ; 9 (9). 955-958
143. Chavant P, Gaillard-Martinie B, Talon R, et al. A new device for rapid evaluation of biofilm formation potential by bacteria. J Microbiol Methods. 2007 ; 68 (3). 605-612
144. Badel S, Laroche C, Gardarin C, et al. New method showing the influence of matrix components in Leuconostoc mesenteroides biofilm formation. Appl Biochem Biotechnol. 2008 ; 151 (2-3). 364-370
145. Tré-Hardy M, Macé C, El Manssouri N, et al. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model. Int J Antimicrob Agents. 2009 ; 33 (1). 40-45
146. Sulaeman S, Le Bihan G, Rossero A, et al. Comparison between the biofilm initiation of Campylobacter jejuni and Campylobacter coli strains to an inert surface using BioFilm Ring Test®. J Appl Microbiol. 2010 ; 108 (4). 1303-1312
147. Honraet K, Nelis H. Use of the modified Robbins device and fluorescent staining to screen plant extracts for the inhibition of S. mutans biofilm formation. J Microbiol Methods. 2006 ; 64 (2). 217-224
148. Krom BP, Buijssen K, Busscher HJ, et al Candida albicans: Methods and Protocols. Cihlar RL Calderone RA, ed. Humana Press ; 45-54.
149. Leunisse C, Van Weissenbruch R, Busscher H, et al. The artificial throat: a new method for standardization of in vitro experiments with tracheo-oesophageal voice prostheses. Acta Otolaryngol. 1999 ; 119 (5). 604-608
150. Schwandt LQ, van Weissenbruch R, van der Mei HC, et al. Effect of dairy products on the lifetime of Provox2 voice prostheses in vitro and in vivo. Head Neck. 2005 ; 27 (6). 471-477
151. Curtin J, Cormican M, Fleming G, et al. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother. 2003 ; 47 (10). 3145-3148
152. Buckingham-Meyer K, Goeres DM, Hamilton MA. Comparative evaluation of biofilm disinfectant efficacy tests. J Microbiol Methods. 2007 ; 70 (2). 236-244
153. Donlan R, Piede J, Heyes C, et al. Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time. Appl Environ Microbiol. 2004 ; 70 (8). 4980-4988
154. Goeres DM, Loetterle LR, Hamilton MA, et al. Statistical assessment of a laboratory method for growing biofilms. Microbiology. 2005 ; 151 (3). 757-762
155. Honraet K, Goetghebeur E, Nelis HJ. Comparison of three assays for the quantification of Candida biomass in suspension and CDC reactor grown biofilms. J Microbiol Methods. 2005 ; 63 (3). 287-295
156. Nailis H, Vandenbroucke R, Tilleman K, et al. Monitoring ALS1 and ALS3 gene expression during in vitro Candida albicans biofilm formation under continuous flow conditions. Mycopathologia. 2009 ; 167 (1). 9-17
157. Parra-Ruiz J, Vidaillac C, Rose WE, et al. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm. Antimicrob Agents Chemother. 2010 ; 54 (10). 4329-4334
158. Agostinho A, James G, Wazni O, et al. Inhibition of Staphylococcus aureus biofilms by a novel antibacterial envelope for use with implantable cardiac devices. Clin Transl Sci. 2009 ; 2 (3). 193-198
159. Gilmore BF, Hamill TM, Jones DS, et al. Validation of the CDC biofilm reactor as a dynamic model for assessment of encrustation formation on urological device materials. J Biomed Mater Res B Appl Biomater. 2010 ; 93 (1). 128-140
160. Green CB, Cheng G, Chandra J, et al. RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology. 2004 ; 150 (2). 267-275
161. Woodworth BA, Tamashiro E, Bhargave G, et al. An in vitro model of Pseudomonas aeruginosa biofilms on viable airway epithelial cell monolayers. Am J Rhinol. 2008 ; 22 (3). 235-238
162. Vollmer T, Hinse D, Kleesiek K, et al. Interactions between endocarditis-derived Streptococcus gallolyticus subsp. gallolyticus isolates and human endothelial cells. BMC Microbiol. 2010 ; 10 (1). 78
163. Kim J, Hegde M, Jayaraman A. Microfluidic co-culture of epithelial cells and bacteria for investigating soluble signal-mediated interactions. J Vis Exp. 2010 ;:
164. Kim J, Hegde M, Jayaraman A. Co-culture of epithelial cells and bacteria for investigating host-pathogen interactions. Lab Chip. 2010 ; 10 (1). 43-50
165. Pompilio A, Crocetta V, Confalone P, et al. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiol. 2010 ; 10 (1). 102
166. Weibel DB, DiLuzio WR, Whitesides GM. Microfabrication meets microbiology. Nat Rev Microbiol. 2007 ; 5 (3). 209-218
167. Benoit MR, Conant CG, Ionescu-Zanetti C, et al. New device for high-throughput viability screening of flow biofilms. Appl Environ Microbiol. 2010 ; 76 (13). 4136-4142
168. Conant CG, Schwartz MA, Ionescu-Zanetti C. Well plate-coupled microfluidic devices designed for facile image-based cell adhesion and transmigration assays. J Biomol Screen. 2010 ; 15 (1). 102-106
169. Ding AM, Palmer RJ, Cisar JO, et al. Shear-enhanced oral microbial adhesion. Appl Environ Microbiol. 2010 ; 76 (4). 1294-1297
170. Darby C, Hsu JW, Ghori N, et al. Caenorhabditis elegans: plague bacteria biofilm blocks food intake. Nature. 2002 ; 417 (6886). 243-244
171. Begun J, Gaiani JM, Rohde H, et al. Staphylococcal biofilm exopolysaccharide protects against Caenorhabditis elegans immune defenses. PLoS Pathog. 2007 ; 3 (4). e57
172. Drace K, Darby C. The hmsHFRS operon of Xenorhabdus nematophila is required for biofilm attachment to. Caenorhabditis elegans. Appl Environ Microbiol. 2008 ; 74 (14). 4509-4515
173. Aicová M, Kucharíková S, Tournu H, et al. Candida albicans biofilm formation in a new in vivo rat model. Microbiology. 2010 ; 156 (3). 909-919
174. Van Wijngaerden E, Peetermans W, Vandersmissen J, et al. Foreign body infection: a new rat model for prophylaxis and treatment. J Antimicrob Chemother. 1999 ; 44 (5). 669-674
175. Engelsman AF, Van der Mei HC, Francis KP, et al. Real time noninvasive monitoring of contaminating bacteria in a soft tissue implant infection model. J Biomed Mater Res B Appl Biomater. 2009 ; 88 (1). 123-129
176. Nakamoto DA, Haaga JR, Bove P, et al. Use of fibrinolytic agents to coat wire implants to decrease infection: an animal model. Invest Radiol. 1995 ; 30 (6). 341-344
177. Nejadnik MR, Engelsman AF, Fernandez ICS, et al. Bacterial colonization of polymer brush-coated and pristine silicone rubber implanted in infected pockets in mice. J Antimicrob Chemother. 2008 ; 62 (6). 1323-1325
178. Kristian SA, Golda T, Ferracin F, et al. The ability of biofilm formation does not influence virulence of Staphylococcus aureus and host response in a mouse tissue cage infection model. Microb Pathog. 2004 ; 36 (5). 237-245
179. Handke LD, Rupp ME Biofilms, infections and antimicrobial therapy. Pace JL Rupp ME Finch RG, ed. Boca Raton, FL: CRC Press ; 2006: 289-304.
180. Zimmerli W, Waldvogel FA, Vaudaux P, et al. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis. 1982 ; 146 (4). 487-497
181. Goerke C, Fluckiger U, Steinhuber A, et al. Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of α-toxin during device-related infection resolved by direct quantitative transcript analysis. Mol Microbiol. 2001 ; 40 (6). 1439-1447
182. Murillo O, Domenech A, Garcia A, et al. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible. Staphylococcus aureus. Antimicrob Agents Chemother. 2006 ; 50 (12). 4011-4017
183. Fluckiger U, Ulrich M, Steinhuber A, et al. Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model. Infect Immun. 2005 ; 73 (3). 1811-1819
184. Kristian SA, Lauth X, Victor N, et al. Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J Infect Dis. 2003 ; 188 (3). 414-423
185. Coenye T, Vandamme P Molecular microbiology and genomics. Wymondham: Horizon Bioscience ; 2006 :
186. Cheung A, Moss R, Kurland G, et al. Chronic Pseudomonas aeruginosa endobronchitis in rhesus monkeys: II. A histopathologic analysis. J Med Primatol. 1993 ; 22 (4). 257-262
187. Cheung A, Moss R, Leong A, et al. Chronic Pseudomonas aeruginosa endobronchitis in rhesus monkeys: I. Effects of pentoxifylline on neutrophil influx. J Med Primatol. 1992 ; 21 (7-8). 357-362
188. Grimwood K, To M, Rabin HR, et al. Subinhibitory antibiotics reduce Pseudomonas aeruginosa tissue injury in the rat lung model. J Antimicrob Chemother. 1989 ; 24 (6). 937-945
189. Yanagihara K, Tomono K, Sawai T, et al. Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. Am J Respir Crit Care Med. 1997 ; 155 (1). 337-342
190. Nagata T, Mukae H, Kadota J, et al. Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model. Antimicrob Agents Chemother. 2004 ; 48 (6). 2251-2259
191. Yanagihara K, Tomono K, Sawai T, et al. Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. J Antimicrob Chemother. 2000 ; 46 (1). 69-72
192. Hoffmann N, Jensen PØ, Stub C, et al. Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect Immun. 2005 ; 73: 2504-2514
193. Nickel J, Olson M, McLean R, et al. An ecological study of infected urinary stone genesis in an animal model. Br J Urol. 1987 ; 59 (1). 21-30
194. Morck D, Lam K, McKay S, et al. Comparative evaluation of fleroxacin, ampicillin, trimethoprimsulfamethoxazole, and gentamicin as treatments of catheter-associated urinary tract infection in a rabbit model. Int J Antimicrob Agents. 1994 ; 4: S21 - S27
195. Morck D, Olson M, McKay S, et al. Therapeutic efficacy of fleroxacin for eliminating catheter-associated urinary tract infection in a rabbit model. Am J Med. 1993 ; 94 (3A). 23S - 30S
196. Olson ME, Nickel JC, Khoury AE, et al. Amdinocillin treatment of catheter-associated bacteriuria in rabbits. J Infect Dis. 1989 ; 159: 1065-1072
197. Fung L, Mittelman M, Thorner P, et al. A novel rabbit model for the evaluation of biomaterial associated urinary tract infection. Can J Urol. 2003 ; 10 (5). 2007-2012
198. Darouiche RO, Mansouri MD, Gawande PV, et al. Efficacy of combination of chlorhexidine and protamine sulphate against device-associated pathogens. J Antimicrob Chemother. 2008 ; 61 (3). 651-657
199. Hachem R, Reitzel R, Borne A, et al. Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results. Antimicrob Agents Chemother. 2009 ; 53 (12). 5145-5149
200. Ehrlich GD, Veeh R, Wang X, et al. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA. 2002 ; 287 (13). 1710-1715
201. Post JC. Candidate's thesis: direct evidence of bacterial biofilms in otitis media. The Laryngoscope. 2001 ; 111 (12). 2083-2094
202. Kaplan JB, Velliyagounder K, Ragunath C, et al. Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. J Bacteriol. 2004b ; 186: 8213-8220